Cardio Diagnostics Holdings, Inc. CDIO
1.86 USD +0.04 (+2.20%)
At closeNov 10, 2026, 4:00 PM EST
1.86 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
1.81 Day range 1.90
0.97 52-week range 7.91
- YTD
- -31.37%
- 1 year
- -51.81%
News
defenseworld.net Critical Analysis: Genmab A/S (NASDAQ:GMAB) versus Cardio Diagnostics (NASDAQ:CDIO) Genmab A/S (NASDAQ: GMAB - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…
defenseworld.net Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Shares Shorted: Short Interest Down 77.7% in September Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO - Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 5,259 shares,…
seekingalpha.com Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript
defenseworld.net Cardio Diagnostics (NASDAQ:CDIO) & Sutro Biopharma (NASDAQ:STRO) Head-To-Head Analysis Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare…
gurufocus.com Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges [url="]Cardio Diagnostics Holdings, Inc.[/url] (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the release of a new edit
businesswire.com Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has released a new edition of the company's rural health report: The State of Rural Hospitals and Cardiovascular Care.
seekingalpha.com Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript
businesswire.com Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa.
businesswire.com Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor conference call on Thursday, August 20, 2026, at 3 p.m. Central Time.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Friday's after-market session. The market value of their outstanding shares is at $12.7 million. iTonic…
businesswire.com Atlas Healthcare Physicians to Cover Cardio Diagnostics' Precision Cardiovascular Medicine Tests Across Its Network CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics' tests, Epi+Gen CHD™ and PrecisionCHD™.
businesswire.com Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will exhibit at four upcoming national benefits conferences.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session 
globenewswire.com IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc. AUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce…
benzinga.com Cardio Diagnostics Hldgs Q1 EPS $(0.63) Up From $(0.97) YoY, Sales $2.680K Up From $940.000 YoY Cardio Diagnostics Hldgs (NASDAQ:CDIO) reported quarterly losses of $(0.63) per share. This is a 35.05 percent increase over losses of $(0.97) per share from the same period last year. The company…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 10 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com Looking Into Cardio Diagnostics Holdings Inc's Recent Short Interest
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
businesswire.com CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026 CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will host an investor conference call on Thursday, February 19, 2026, at 3 p.m. Central Time.
businesswire.com Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026 CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will host an investor conference call on Wednesday, February 18, 2026, at 3 p.m. Central Time.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
defenseworld.net Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) and Allarity Therapeutics (NASDAQ: ALLR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will…
benzinga.com Cardio Diagnostics Bets On India To Scale AI Heart Diagnostics Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs partner to bring PrecisionCHD test to India, aiming to address high heart disease rates.
benzinga.com Market-Moving News for January 7th GLUE: 42% | Monte Rosa Therapeutics shares are trading higher after the company announced it will present interim clinical results from the ongoing Phase 1 study of NEK7-directed MGD MRT-8102. VTYX:…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
businesswire.com Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Aimil Ltd., and Dr. Lal PathLabs announce strategic agreement to launch Cardio Diagnostics' PrecisionCHD™ test in India.
businesswire.com Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community EDINA, Minn. & CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced a partnership with the Southdale YMCA, becoming the second YMCA location nationally to partner with Cardio Diagnostics.
businesswire.com Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that CMS has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD™ and PrecisionCHD™ tests.
benzinga.com Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that…
businesswire.com Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD's Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will be presenting new data at the American Heart Association (AHA) Scientific Sessions.
prnewswire.com NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance /PRNewswire/ -- Naples Comprehensive Health (NCH) and Caristo Diagnostics announced that NCH Rooney Heart Institute has become the first hospital in the nation
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Cardio Diagnostics Enters Partnerships With 15 New U.S. Provider Organizations, Expanding Adoption Of Its AI-driven Blood Tests, Epi+Gen CHD And PrecisionCHD Which Aim To Improve Prevention, Detection, And Management Of Coronary Heart Disease Across Diverse Clinical Settings Growing Adoption of AI-Driven Precision Cardiovascular Medicine Tests Spans Concierge, Functional Medicine, and Primary Care PracticesCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven…
benzinga.com Cardio Diagnostics Hldgs Q2 EPS $(0.97) Beats $(1.80) Estimate, Sales $7.475K Miss $75.000K Estimate Cardio Diagnostics Hldgs (NASDAQ:CDIO) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.80) by 46.11 percent. This is a 46.11 percent increase over…